Successful Use of Eculizumab for Prevention of Atypical Hemolytic Uremic Syndrome Recurrence in a Pregnant Kidney Transplant Recipient with CFH Gene Mutation: A Case Report and Literature Review
Bibliographic record
Abstract
Introduction: Eculizumab is a humanized monoclonal antibody targeting C5, used in the treatment of atypical hemolytic uremic syndrome (aHUS). It is accepted as maintenance therapy for the prevention of recurrent aHUS post kidney transplant (KTx), however, clinical experience with its use during pregnancy is limited. Case Description: 36-year-old woman with history of end stage renal disease secondary to aHUS with confirmed complement factor H gene mutation was treated with hemodialysis, plasmapheresis, rituximab and vincristine. She received a standard-criteria deceased donor KTx in 2013. Eculizumab was administered in the perioperative period at a dose of 1200 mg IV, followed by 1200 mg Q1W for 2 weeks, and then Q2W thereafter as maintenance therapy. In 2016, she had a planned pregnancy during which eculizumab was continued. Biomarkers of hemolysis and kidney function were closely monitored. Despite the development of pre-eclampsia resulting in preterm delivery at 33W, the patient delivered a healthy infant and had well-preserved allograft function with no aHUS recurrence. 8 years later, no complications are observed and her child is developing normally. Pubmed search was conducted for reports of prophylactic use of eculizumab in aHUS pregnant KTx recipients between 1993 and 2024. 35 articles were found, of which, three fulfilled our criteria (table 1). Discussion: Although eculizumab is considered safe during pregnancy, its use in pregnant KTx recipients is rare given the lack of relevant pharmacological data and unknown long-term effects on the offspring. We report for the first time, 8-year follow up favorable maternal and fetal outcomes and provide a literature review of similar cases. We conclude that maintenance eculizumab is a plausible option for prevention of aHUS recurrence in pregnant women who received KTx. Close monitoring of hemolytic markers and kidney function is recommended to ensure early detection and management of complications.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".